Atlas Venture Fund XI, L.P. - Nov 24, 2021 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
10%+ Owner
Signature
Atlas Venture Fund XI, LP, By: Atlas Venture Associates XI, L.P., it's general partner, By: Atlas Venture Associates XI, LLC, its general partner, By: Ommer Chohan, Chief Financial Officer, /s/ Ommer Chohan
Stock symbol
DAWN
Transactions as of
Nov 24, 2021
Transactions value $
$0
Form type
4
Date filed
11/29/2021, 04:30 PM
Previous filing
Oct 26, 2021
Next filing
Sep 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Other $0 -801K -10% $0.00 7.21M Nov 24, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI") to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted by Atlas Venture Fund XI pursuant to Rule 10b5-1 on July 16, 2021.